Korea Readying Itself For New Era Of Digital Therapeutics
Pivotal Trials Underway But Reimbursement Lacking
Scrip takes a look at the current landscape in the South Korean digital therapeutics sector, where some remaining gaps in regulation and reimbursement are seen but multiple products are now progressing through pivotal local clinical trials.
You may also be interested in...
The Pink Sheet’s roundup of key regulatory issues in Korea for 2022 and outlook for this year.
A policy report by a major South Korean pharma industry association puts forward suggestions on what it will take for a new pan-government control tower to function properly.
At the recent World Bio Summit in Seoul, global health leaders discussed international cooperation strategies and policies to prepare for the next pandemic, with a focus on rapid vaccine development.